Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study

Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study

(2011) Tiziano Barbui et al.   JOURNAL OF CLINICAL ONCOLOGY

Are Chronic Myeloid Leukemia Patients More at Risk for Second Malignancies? A Population-based Study

(2010) P. Rebora et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms

(2010) N. H. Thoennissen et al.   BLOOD

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

(2010) Peter M Rothwell et al.   LANCET

Increased Risk of Lymphoid Neoplasms in Patients with Philadelphia Chromosome-Negative Myeloproliferative Neoplasms

(2009) A. M. Vannucchi et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Cancer incidence and risk factors after solid organ transplantation

(2009) Claire M. Vajdic et al.   INTERNATIONAL JOURNAL OF CANCER

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

(2009) A Hochhaus et al.   LEUKEMIA

Impact of COPD on Outcome Among Patients With Complicated Peptic Ulcer

(2008) Steffen Christensen et al.   CHEST

Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up

(2008) F. Palandri et al.   HAEMATOLOGICA

Second malignancies in essential thrombocythemia (ET): a retrospective analysis of 331 patients with long-term follow-up from a single institution

(2008) Franca Radaelli et al.   Hematology

Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders

(2008) F Cervantes et al.   LEUKEMIA